Cargando…
Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method
The World Health Organization (WHO) introduced “Coronavirus disease 19” or “COVID-19” as a novel coronavirus in March 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery of effective treatments to fight this worldwide crisis. Artificial intelligence and bio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384336/ https://www.ncbi.nlm.nih.gov/pubmed/35992221 http://dx.doi.org/10.1016/j.asoc.2022.109510 |
_version_ | 1784769432452595712 |
---|---|
author | Taheri, Golnaz Habibi, Mahnaz |
author_facet | Taheri, Golnaz Habibi, Mahnaz |
author_sort | Taheri, Golnaz |
collection | PubMed |
description | The World Health Organization (WHO) introduced “Coronavirus disease 19” or “COVID-19” as a novel coronavirus in March 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery of effective treatments to fight this worldwide crisis. Artificial intelligence and bioinformatics analysis pipelines can assist with finding biomarkers, explanations, and cures. Artificial intelligence and machine learning methods provide powerful infrastructures for interpreting and understanding the available data. On the other hand, pathway enrichment analysis, as a dominant tool, could help researchers discover potential key targets present in biological pathways of host cells that are targeted by SARS-CoV-2. In this work, we propose a two-stage machine learning approach for pathway analysis. During the first stage, four informative gene sets that can represent important COVID-19 related pathways are selected. These “representative genes” are associated with the COVID-19 pathology. Then, two distinctive networks were constructed for COVID-19 related signaling and disease pathways. In the second stage, the pathways of each network are ranked with respect to some unsupervised scorning method based on our defined informative features. Finally, we present a comprehensive analysis of the top important pathways in both networks. Materials and implementations are available at: https://github.com/MahnazHabibi/Pathway. |
format | Online Article Text |
id | pubmed-9384336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93843362022-08-17 Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method Taheri, Golnaz Habibi, Mahnaz Appl Soft Comput Article The World Health Organization (WHO) introduced “Coronavirus disease 19” or “COVID-19” as a novel coronavirus in March 2020. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires the fast discovery of effective treatments to fight this worldwide crisis. Artificial intelligence and bioinformatics analysis pipelines can assist with finding biomarkers, explanations, and cures. Artificial intelligence and machine learning methods provide powerful infrastructures for interpreting and understanding the available data. On the other hand, pathway enrichment analysis, as a dominant tool, could help researchers discover potential key targets present in biological pathways of host cells that are targeted by SARS-CoV-2. In this work, we propose a two-stage machine learning approach for pathway analysis. During the first stage, four informative gene sets that can represent important COVID-19 related pathways are selected. These “representative genes” are associated with the COVID-19 pathology. Then, two distinctive networks were constructed for COVID-19 related signaling and disease pathways. In the second stage, the pathways of each network are ranked with respect to some unsupervised scorning method based on our defined informative features. Finally, we present a comprehensive analysis of the top important pathways in both networks. Materials and implementations are available at: https://github.com/MahnazHabibi/Pathway. The Author(s). Published by Elsevier B.V. 2022-10 2022-08-17 /pmc/articles/PMC9384336/ /pubmed/35992221 http://dx.doi.org/10.1016/j.asoc.2022.109510 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Taheri, Golnaz Habibi, Mahnaz Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method |
title | Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method |
title_full | Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method |
title_fullStr | Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method |
title_full_unstemmed | Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method |
title_short | Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method |
title_sort | comprehensive analysis of pathways in coronavirus 2019 (covid-19) using an unsupervised machine learning method |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384336/ https://www.ncbi.nlm.nih.gov/pubmed/35992221 http://dx.doi.org/10.1016/j.asoc.2022.109510 |
work_keys_str_mv | AT taherigolnaz comprehensiveanalysisofpathwaysincoronavirus2019covid19usinganunsupervisedmachinelearningmethod AT habibimahnaz comprehensiveanalysisofpathwaysincoronavirus2019covid19usinganunsupervisedmachinelearningmethod |